The costs of vascular dementia
- 1 November 2002
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 203-204, 35-39
- https://doi.org/10.1016/s0022-510x(02)00257-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Treatment optionsJournal of the Neurological Sciences, 2002
- Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trialPublished by Elsevier ,2002
- A 5-month, randomized, placebo-controlled trial of galantamine in ADNeurology, 2000
- Galantamine in ADNeurology, 2000
- Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial Commentary: Another piece of the Alzheimer's jigsawBMJ, 1999
- Epidemiology of Dementia and Alzheimer's DiseaseAmerican Journal of Geriatric Psychiatry, 1998
- A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's diseaseNeurology, 1998
- Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment CentersNeurology, 1992
- Epidemiology of Multi-Infarct DementiaAlzheimer Disease & Associated Disorders, 1991
- Randomized Clinical Trial of Daily Aspirin Therapy in Multi‐Infarct DementiaJournal of the American Geriatrics Society, 1989